The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
Patience Setordzi, Xing Chang, Zi Liu, Yingliang Wu, Daiying Zuo
Topics & Concepts
ImmunotherapyPD-L1Immune checkpointMedicineCancer immunotherapyCancer researchPembrolizumabCancerImmune systemBreast cancerPharmacologyImmunologyInternal medicineCancer Immunotherapy and BiomarkersLung Cancer Research StudiesCancer, Stress, Anesthesia, and Immune Response